SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-18-015757
Filing Date
2018-11-13
Accepted
2018-11-13 16:17:06
Documents
89
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 1084391
2 ex10-1.htm EX-10.1 75449
3 ex10-2.htm EX-10.2 78004
4 ex10-3.htm EX-10.3 79069
5 ex31-1.htm EX-31.1 18421
6 ex31-2.htm EX-31.2 18190
7 ex32-1.htm EX-32.1 9378
  Complete submission text file 0001493152-18-015757.txt   5060092

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE FILE immy-20180930.xml EX-101.INS 706682
9 XBRL SCHEMA FILE immy-20180930.xsd EX-101.SCH 54939
10 XBRL CALCULATION FILE immy-20180930_cal.xml EX-101.CAL 87038
11 XBRL DEFINITION FILE immy-20180930_def.xml EX-101.DEF 291641
12 XBRL LABEL FILE immy-20180930_lab.xml EX-101.LAB 372571
13 XBRL PRESENTATION FILE immy-20180930_pre.xml EX-101.PRE 343048
Mailing Address 12264 EL CAMINO REAL SUITE 350 SAN DIEGO CA 92130
Business Address 12264 EL CAMINO REAL SUITE 350 SAN DIEGO CA 92130 858-704-4042
Imprimis Pharmaceuticals, Inc. (Filer) CIK: 0001360214 (see all company filings)

IRS No.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35814 | Film No.: 181178183
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1